Article

Development of in-house, indirect ELISAs for the detection of SARS-CoV-2 spike protein-associated serology in COVID-19 patients in Panama

2021-05-04

Abstract excerpt

COVID-19 is the name of the acute respiratory disease caused by the new coronavirus SARS-CoV-2, a close relative of those that caused the severe outbreaks of SARS and MERS several years ago. Since first appearance on December of 2019, the COVID-19 pandemic has cause extremely high levels of mortality, morbidity, global economic breakdown and the consequent human suffering. While vaccination efforts are not extensi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 78affc9e-bdd2-5ac7-bd9a-e2b52022e6ba
DOI: 10.1101/2021.04.30.21256406

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development of in-house, indirect ELISAs for the detection of SARS-CoV-2 spike protein-associated serology in COVID-19 patients in PanamaDOI 10.1101/2021.04.30.21256406Read

Evaluation of Nucleocapsid and Spike Protein-based ELISAs for detecting antibodies against SARS-CoV-2Semantic proximity Read

Performance assessment of 11 commercial serological tests for SARS-CoV-2 on hospitalized COVID-19 patientsSemantic proximity Read

Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy studySemantic proximity Read

A comparative review of immunoassays for COVID-19 detectionSemantic proximity Read

Advanced Molecular and Immunological Diagnostic Methods to Detect SARS-CoV-2 InfectionSemantic proximity Read

Persistent Levels of Anti-SARS-CoV-2 IgM Antibody Measured by an In-house ELISA in a Convalescent Latin Population Positively Correlate with the Neutralizing Percentages to Several Variants of ConcernSemantic proximity Read

Analysis of IgG, IgA, and IgM antibodies against SARS-CoV-2 spike protein S1 in convalescent and vaccinated patients with the Pfizer-BioNTech and CanSinoBio vaccinesSemantic proximity Read

COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in salivaSemantic proximity Read

Diagnostic accuracy of two commercially available rapid assays for detection of IgG and IgM antibodies to SARS-CoV-2 compared to ELISA in a low-prevalence populationSemantic proximity Read

Serological diagnostic kit of SARS-CoV-2 antibodies using CHO-expressed full-length SARS-CoV-2 S1 proteinsSemantic proximity Read

Analytical Performances of the Point-of-Care BIOSYNEX COVID-19 Ag BSS for the Detection of SARS‐CoV‐2 Nucleocapsid Protein in Nasopharyngeal Swabs: A Prospective Field Evaluation During the COVID-19 Third Wave in FranceSemantic proximity Read

Targets and assay types for COVID-19 diagnosis.Semantic proximity Read